As demonstrated by us, PHD2 deficiency reduces the growth of murine LM8 osteosarcoma and Lewis lung carcinoma, by converting the tumor-promoting activity of transforming growth factor (TGF)-β into a growth-inhibitory activity [30]. This evidence concerns the gene EGLN1 and osteosarcoma.